Immune activity in the CNS parenchyma under various acute and chronic neurodegenerative conditions has been often interpreted as a sign of pathological inflammation. The apparent resemblance of the local neuroinflammatory processes to autoimmune diseases, such as multiple sclerosis (MS), generated the view that, despite differences in etiology and pathology, neurodegenerative disorders with a local inflammatory component can benefit from systemic anti-inflammatory therapy. In addition, as CNS self-reactive T cells are associated with the etiology of MS, autoimmunity was assumed to solely reflect pathology, and therefore, was universally linked to autoimmune disease. Yet, it is becoming increasingly clear that CNS-specific T cells, along with circulating and local innate immune cells, can enhance CNS healing processes following non-infectious injuries, or any deviation from homeostasis, including chronic pathological conditions. Here, we discuss the theory of “protective autoimmunity,” which describes the activity of an immune cell network encompassing effector and regulatory T cells with specificity for CNS antigens, in CNS maintenance and repair. Such an immune network, evoked in response to external and internal threats, functions in a tightly regulated way, ensuring restoration of the brain’s equilibrium and return to homeostasis.
AnkenyDPLucinKMSandersVMMcGaughyVMPopovichPG. 2006. Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem99(4):1073–87.
2.
ArnoldLHenryAPoronFBaba-AmerYvan RooijenNPlonquetA, and others. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med204(5):1057–69.
3.
AsakuraKMillerDJPeaseLRRodriguezM. 1998. Targeting of IgM-κ antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci18(19):7700–8.
4.
BanerjeeRMosleyRLReynoldsADDharAJackson-LewisVGordonPH, and others. 2008. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One3(7):e2740.
5.
BaruchKRon-HarelNGalHDeczkowskaAShifrutENdifonW, and others. 2013. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc Natl Acad Sci U S A110(6):2264–9.
6.
BeersDRHenkelJSZhaoWWangJAppelSH. 2008. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A105(40):15558–63.
7.
ButovskyOKoronyo-HamaouiMKunisGOphirELandaGCohenH, and others. 2006a. Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A103(31):11784–9.
8.
ButovskyOKunisGKoronyo-HamaouiMSchwartzM. 2007. Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer’s disease model. Eur J Neurosci26(2):413–6.
9.
ButovskyOTalpalarAEBen-YaakovKSchwartzM. 2005. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective. Mol Cell Neurosci29(3):381–93.
10.
ButovskyOZivYSchwartzALandaGTalpalarAEPluchinoS, and others. 2006b. Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci31(1):149–60.
11.
CampbellDJKochMA. 2011. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol11(2):119–30.
12.
ChiuIMChenAZhengYKosarasBTsiftsoglouSAVartanianTK, and others. 2008. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A105(46):17913–8.
13.
ClellandCDChoiMRombergCClemensonGDJrFragniereATyersP, and others. 2009. A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science325(5937):210–3.
14.
CohenHZivYCardonMKaplanZMatarMAGidronY, and others. 2006. Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol66(6):552–63.
15.
CohenIR. 1992. The cognitive paradigm and the immunological homunculus. Immunol Today13(12):490–4.
16.
DavidDJSamuelsBARainerQWangJWMarstellerDMendezI, and others. 2009. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron62(4):479–93.
17.
DengWAimoneJBGageFH. 2010. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci11(5):339–50.
18.
DereckiNCCardaniANYangCHQuinniesKMCrihfieldALynchKR, and others. 2010. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med207(5):1067–80.
19.
DereckiNCCronkJCLuZXuEAbbottSBGuyenetPG, and others. 2012. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature484(7392):105–9.
20.
DumanRSMonteggiaLM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry59(12):1116–27.
21.
EkdahlCTKokaiaZLindvallO. 2009. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience158(3):1021–9.
22.
El KhouryJToftMHickmanSEMeansTKTeradaKGeulaC, and others. 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med13(4):432–8.
23.
FisherJLevkovitch-VerbinHSchoriHYolesEButovskyOKayeJF, and others. 2001. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci21(1):136–42.
GaleaIBechmannIPerryVH. 2007. What is immune privilege (not)?Trends Immunol28(1):12–8.
26.
GargSKBanerjeeRKipnisJ. 2008. Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype. J Immunol180(6):3866–73.
27.
GinhouxFGreterMLeboeufMNandiSSeePGokhanS, and others. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science330(6005):841–5.
28.
GoebelsNHofstetterHSchmidtSBrunnerCWekerleHHohlfeldR. 2000. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain123(Pt 3):508–18.
29.
GovermanJWoodsALarsonLWeinerLPHoodLZallerDM. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell72(4):551–60.
30.
GruverALHudsonLLSempowskiGD. 2007. Immunosenescence of ageing. J Pathol211(2):144–56.
31.
HanischUKKettenmannH. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci10(11):1387–94.
32.
HaubenEButovskyONevoUYolesEMoalemGAgranovE, and others. 2000a. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci20(17):6421–30.
33.
HaubenENevoUYolesEMoalemGAgranovEMorF, and others. 2000b. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet355(9200):286–7.
34.
HawkesCAMcLaurinJ. 2009. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A106(4):1261–6.
35.
HirschbergDLMoalemGHeJMorFCohenIRSchwartzM. 1998. Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J Neuroimmunol89(1-2):88–96.
36.
HofstetterHHSewellDLLiuFSandorMForsthuberTLehmannPV, and others. 2003. Autoreactive T cells promote post-traumatic healing in the central nervous system. J Neuroimmunol134(1-2):25–34.
37.
HohlfeldRKerschensteinerMStadelmannCLassmannHWekerleH. 2006. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol Sci27(Suppl 1):S1–7.
38.
HuangDWMcKerracherLBraunPEDavidS. 1999. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron24(3):639–47.
39.
IshibashiSMaricDMouYOhtaniRRuetzlerCHallenbeckJM. 2009. Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab29(3):606–20.
40.
JohnsonTVCamrasCBKipnisJ. 2007. Bacterial DNA confers neuroprotection after optic nerve injury by suppressing CD4+CD25+ regulatory T-cell activity. Invest Ophthalmol Vis Sci48(8):3441–9.
41.
JonesJLAndersonJMPhuahCLFoxEJSelmajKMargolinD, and others. 2010. Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Brain133(Pt 8):2232–47.
42.
JonesTBBassoDMSodhiAPanJZHartRPMacCallumRC, and others. 2002. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci22(7):2690–700.
43.
KerschensteinerMGallmeierEBehrensLLealVVMisgeldTKlinkertWE, and others. 1999. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?J Exp Med189(5):865–70.
44.
KigerlKAGenselJCAnkenyDPAlexanderJKDonnellyDJPopovichPG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci29(43):13435–44.
45.
KilKZangYCYangDMarkowskiJFuocoGSVendettiGC, and others. 1999. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Immunol98(2):201–7.
46.
KipnisJAvidanHCaspiRRSchwartzM. 2004a. Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia. Proc Natl Acad Sci U S A101(Suppl 2):14663–9.
47.
KipnisJAvidanHMarkovichYMizrahiTHaubenEPrigozhinaTB, and others. 2004b. Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells. Eur J Neurosci19(5):1191–8.
48.
KipnisJCardonMAvidanHLewitusGMMordechaySRollsA, and others. 2004c. Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. J Neurosci24(27):6133–43.
49.
KipnisJCohenHCardonMZivYSchwartzM. 2004d. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci U S A101(21):8180–5.
50.
KipnisJMizrahiTHaubenEShakedIShevachESchwartzM. 2002a. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci U S A99(24):15620–5.
51.
KipnisJMizrahiTYolesEBen-NunASchwartzM. 2002b. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol130(1-2):78–85.
52.
KipnisJSchwartzM. 2005. Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-cells at the crossroads of health and disease. Neuromolecular Med7(3):197–206.
53.
KipnisJYolesEPoratZCohenAMorFSelaM, and others. 2000. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A97(13):7446–51.
54.
KnapmanAHeinzmannJMHellwegRHolsboerFLandgrafRToumaC. 2010. Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. J Psychiatr Res44(9):566–75.
55.
KochMATucker-HeardGPerdueNRKillebrewJRUrdahlKBCampbellDJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol10(6):595–602.
56.
KokaiaZMartinoGSchwartzMLindvallO. 2012. Cross-talk between neural stem cells and immune cells: the key to better brain repair?Nat Neurosci15(8):1078–87.
57.
KornTReddyJGaoWBettelliEAwasthiAPetersenTR, and others. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med13(4):423–31.
58.
Koronyo-HamaouiMKoMKKoronyoYAzoulayDSeksenyanAKunisG, and others. 2009. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J Neurochem111(6):1409–24.
59.
KunisGBaruchKRosenzweigNKertserAMillerOBerkutzkiT, and others. 2013. IFN-γ-dependent activation of the brain’s choroid plexus for CNS immune surveillance and repair. Brain136(Pt 11):3427–40.
60.
LehmannPVTargoniOSForsthuberTG. 1998. Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol Rev164:53–61.
61.
LewitusGMCohenHSchwartzM. 2008. Reducing post-traumatic anxiety by immunization. Brain Behav Immun22(7):1108–14.
62.
LewitusGMSchwartzM. 2009. Behavioral immunization: immunity to self-antigens contributes to psychological stress resilience. Mol Psychiatry14(5):532–6.
63.
LewitusGMWilf-YarkoniAZivYShabat-SimonMGersnerRZangenA, and others. 2009. Vaccination as a novel approach for treating depressive behavior. Biol Psychiatry65(4):283–8.
64.
LieszASuri-PayerEVeltkampCDoerrHSommerCRivestS, and others. 2009. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med15(2):192–9.
65.
LinkerRALeeDHDemirSWieseSKruseNSiglientiI, and others. 2010. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain133(Pt 8):2248–63.
66.
LiuJGongNHuangXReynoldsADMosleyRLGendelmanHE. 2009. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J Immunol182(6):3855–65.
67.
LondonAItskovichEBenharIKalchenkoVMackMJungS, and others. 2011. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J Exp Med208(1):23–39.
68.
MackayIR. 2010. Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev9(5):A251–8.
69.
MartinoGPluchinoSBonfantiLSchwartzM. 2011. Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev91(4):1281–304.
70.
MillerAH. 2010. Depression and immunity: a role for T cells?Brain Behav Immun24(1):1–8.
71.
MillerAHMaleticVRaisonCL. 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry65(9):732–41.
72.
MoalemGLeibowitz-AmitRYolesEMorFCohenIRSchwartzM. 1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med5(1):49–55.
NahrendorfMSwirskiFKAikawaEStangenbergLWurdingerTFigueiredoJL, and others. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med204(12):3037–47.
75.
OestreichKJWeinmannAS. 2012. Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors. Nat Rev Immunol12(11):799–804.
76.
OlssonTDienerPLjungdahlAHojebergBvan der MeidePHKristenssonK. 1992. Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity13(2):117–26.
77.
OlssonTSunJBSoldersGXiaoBGHojebergBEkreHP, and others. 1993. Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J Neurol Sci117(1-2):130–9.
78.
PerryVHNicollJAHolmesC. 2010. Microglia in neurodegenerative disease. Nat Rev Neurol6(4):193–201.
79.
PopovichPGStokesBTWhitacreCC. 1996. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res45(4):349–63.
80.
RadjaviASmirnovIKipnisJ. 2013. Brain antigen-reactive CD4 T cells are sufficient to support learning behavior in mice with limited T cell repertoire. Brain Behav ImmunSep5. [Epub ahead of print]
81.
RansohoffRMKivisakkPKiddG. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol3(7):569–81.
82.
RapalinoOLazarov-SpieglerOAgranovEVelanGJYolesEFraidakisM, and others. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med4(7):814–21.
83.
RaySBritschgiMHerbertCTakeda-UchimuraYBoxerABlennowK, and others. 2007. Classification and prediction of clinical Alzheimer’s diagnosis based on plasma signaling proteins. Nat Med13(11):1359–62.
84.
RivestS. 2009. Regulation of innate immune responses in the brain. Nat Rev Immunol9(6):429–39.
85.
RollsAShechterRLondonASegevYJacob-HirschJAmariglioN, and others. 2008. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med5(8):e171.
RollsAShechterRSchwartzM. 2009. The bright side of the glial scar in CNS repair. Nat Rev Neurosci10(3):235–41.
88.
Ron-HarelNCardonMSchwartzM. 2011. Brain homeostasis is maintained by “danger” signals stimulating a supportive immune response within the brain’s borders. Brain Behav Immun25(5):1036–43.
89.
Ron-HarelNSchwartzM. 2009. Immune senescence and brain aging: can rejuvenation of immunity reverse memory loss? Trends Neurosci32(7):367–75.
90.
Ron-HarelNSegevYLewitusGMCardonMZivYNetanelyD, and others. 2008. Age-dependent spatial memory loss can be partially restored by immune activation. Rejuvenation Res11(5):903–13.
91.
RosenblumMDGratzIKPawJSLeeKMarshak-RothsteinAAbbasAK. 2011. Response to self antigen imprints regulatory memory in tissues. Nature480(7378):538–42.
92.
RuffellDMourkiotiFGambardellaAKirstetterPLopezRGRosenthalN, and others. 2009. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A106(41):17475–80.
93.
SchoriHKipnisJYolesEWoldeMussieERuizGWheelerLA, and others. 2001. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A98(6):3398–403.
94.
SchoriHLantnerFShacharISchwartzM. 2002. Severe immunodeficiency has opposite effects on neuronal survival in glutamate-susceptible and -resistant mice: adverse effect of B cells. J Immunol169(6):2861–5.
95.
SchwartzM. 2010. The emergence of a new science of the mind: immunology benefits the mind. Mol Psychiatry15(4):337–8.
96.
SchwartzMBaruchK. 2012. Vaccine for the mind: Immunity against self at the choroid plexus for erasing biochemical consequences of stressful episodes. Hum Vaccin Immunother8(10):1465–8.
97.
SchwartzMKipnisJ. 2002. Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a ‘need’ and a ‘risk’. Trends Immunol23(11):530–4.
98.
SchwartzMShechterR. 2010a. Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease. Mol Psychiatry15(4):342–54.
SeksenyanARon-HarelNAzoulayDCahalonLCardonMRogeriP, and others. 2010. Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis. J Cell Mol Med14(10):2470–82.
101.
SeligmanMEMaierSF. 1967. Failure to escape traumatic shock. J Exp Psychol74(1):1–9.
102.
SemanaGGauslingRJacksonRAHaflerDA. 1999. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J Autoimmun12(4):259–67.
103.
SerpeCJByramSCSandersVMJonesKJ. 2005. Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice. Brain Behav Immun19(2):173–80.
104.
ShakedITchoreshDGersnerRMeiriGMordechaiSXiaoX, and others. 2005. Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem92(5):997–1009.
105.
ShechterRLondonASchwartzM. 2013a. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol13(3):206–18.
106.
ShechterRLondonAVarolCRaposoCCusimanoMYovelG, and others. 2009. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med6(7):e1000113.
107.
ShechterRMillerOYovelGRosenzweigNLondonARuckhJ, and others. 2013b. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity38(3):555–69.
108.
ShechterRRaposoCLondonASagiISchwartzM. 2011. The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One6(12):e27969.
109.
ShechterRZivYSchwartzM. 2007. New GABAergic interneurons supported by myelin-specific T cells are formed in intact adult spinal cord. Stem Cells25(9):2277–82.
110.
SicotteMTsatasOJeongSYCaiCQHeZDavidS. 2003. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol Cell Neurosci23(2):251–63.
111.
SilbermanDMAyelli-EdgarVZorrilla-ZubileteMZieherLMGenaroAM. 2004. Impaired T-cell dependent humoral response and its relationship with T lymphocyte sensitivity to stress hormones in a chronic mild stress model of depression. Brain Behav Immun18(1):81–90.
112.
SimardARSouletDGowingGJulienJPRivestS. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer’s disease. Neuron49(4):489–502.
SteffenBJBreierGButcherECSchulzMEngelhardtB. 1996. ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol148(6):1819–38.
115.
SteinmanL. 1995. Escape from “horror autotoxicus”: pathogenesis and treatment of autoimmune disease. Cell80(1):7–10.
116.
StreitWJXueQS. 2010. The brain’s aging immune system. Aging Dis1(3):254–261.
117.
SwirskiFKNahrendorfMEtzrodtMWildgruberMCortez-RetamozoVPanizziP, and others. 2009. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science325(5940):612–6.
118.
TanapatPHastingsNBRydelTAGaleaLAGouldE. 2001. Exposure to fox odor inhibits cell proliferation in the hippocampus of adult rats via an adrenal hormone-dependent mechanism. J Comp Neurol437(4):496–504.
119.
TargoniOSLehmannPV. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med187(12):2055–63.
120.
TaubDDLongoDL. 2005. Insights into thymic aging and regeneration. Immunol Rev205:72–93.
121.
VarolCVallon-EberhardAElinavEAychekTShapiraYLucheH, and others. 2009. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity31(3):502–12.
122.
VigliettaVBaecher-AllanCWeinerHLHaflerDA. 2004. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med199(7):971–9.
123.
WangWZOlssonTKostulasVHojebergBEkreHPLinkH. 1992. Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol88(1):157–62.
124.
WellerROEngelhardtBPhillipsMJ. 1996. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol6(3):275–88.
125.
WinnerBKohlZGageFH. 2011. Neurodegenerative disease and adult neurogenesis. Eur J Neurosci33(6):1139–51.
126.
WolfSAFisherJBechmannISteinerBKwidzinskiENitschR. 2002. Neuroprotection by T-cells depends on their subtype and activation state. J Neuroimmunol133(1-2):72–80.
127.
WolfSASteinerBAkpinarliAKammertoensTNassensteinCBraunA, and others. 2009. CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J Immunol182(7):3979–84.
128.
Wyss-CorayTLinCYanFYuGQRohdeMMcConlogueL, and others. 2001. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat Med7(5):612–8.
129.
XingYHogquistKA. 2012. T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol4(6).
130.
YirmiyaRGoshenI. 2011. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun25(2):181–213.
131.
YolesEHaubenEPalgiOAgranovEGothilfACohenA, and others. 2001. Protective autoimmunity is a physiological response to CNS trauma. J Neurosci21(11):3740–8.
132.
ZhengYChaudhryAKasAdeRoosPKimJMChuTT, and others. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature458(7236):351–6.
133.
ZiemssenTKumpfelTKlinkertWENeuhausOHohlfeldR. 2002. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain125(Pt 11):2381–91.
134.
ZivYAvidanHPluchinoSMartinoGSchwartzM. 2006a. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci U S A103(35):13174–9.
135.
ZivYRonNButovskyOLandaGSudaiEGreenbergN, and others. 2006b. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci9(2):268–75.
136.
ZivYSchwartzM. 2008. Orchestrating brain-cell renewal: the role of immune cells in adult neurogenesis in health and disease. Trends Mol Med14(11):471–8.
